Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Appetite Regulation”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 505 records · Page 28Linked to original sources

Energy utilization by the broiler chicken as affected by various fats and fat levels.

Two experiments were designed to investigate the effects of fat supplementation at different levels on energy utilization by the broiler chicken. In one experiment, finisher diets containing 2.5, 5.0, or 10.0% of added corn oil (CO), poultry oil (PO), tallow (T), or a commercial hydrolyzed animal-vegetable fat blend (HB) were fed. In the second experiment, starter diets containing 0, 2.5, or 7.5% added CO, PO or HB were fed. Metabolizable energy (ME) values were not controlled through formulation but were determined experimentally. Energy retention was measured by a slaughter technique, and metabolic energy losses were calculated as the difference between metabolizable energy intake and energy deposition in the carcass. Broilers that were fed PO, T, and HB failed to adjust feed intake to control caloric intake. They ate significantly more ME calories per day when these fat sources were fed, gained more, were fatter, and had a lower feed:gain ratio than broilers fed no added fat or lower levels of fat. Failure to regulate caloric intake when fats are added to diets may be a component of the "extra caloric" effect of fat. Broilers which were fed CO tended to regulate their caloric intake better than those which are fed PO, T, and HB. It was not determined if CO is less palatable than the other fat sources or if the unsaturated fatty acids metabolically regulate appetite. When CO was fed, broilers tended to have lower feed:gain ratios than when the other fats were fed. There was an indication that daily heat production was less when CO was fed, which would suggest a lower heat increment. Fatty acid analysis verified the efficient use of dietary fats for adipose deposition and suggested a disproportionately greater use of the unsaturated fatty acids for carcass lipids.

Animal Feed↗

Intraperitoneal insulin reduces plasma leptin concentration in diabetic patients on CAPD.

OBJECTIVE: To determine the effects of subcutaneous (SC) and intraperitoneal (IP) insulin on serum leptin concentration in type I diabetic patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis (CAPD). DESIGN: Prospective, open, before-after study. SETTING: Tertiary-care university hospital. PARTICIPANTS: Twelve type I diabetic patients with stabilized CAPD, age 43.9 +/- 2.8 years, and duration of diabetes 30.4 +/- 3.5 years. INTERVENTION: After stabilized CAPD therapy, all patients were treated first with SC insulin for a median of 3 months, and thereafter with IP insulin for another 3 months. MAIN OUTCOME MEASURES: Plasma leptin, insulin sensitivity with euglycemic clamp, and glycemic and uremic status after both treatment periods. RESULTS: During SC insulin therapy, plasma leptin concentration was significantly higher than during IP insulin (19.8 +/- 5.9 ng/mL and 12.8 +/- 6.2 ng/mL, respectively; p < 0.001). Leptin concentration was higher in CAPD patients and was related to body mass index in both genders. No correlation was detected between plasma leptin and fasting insulin, glycemic control, glucose disposal rate, or serum lipids. CONCLUSION: Plasma leptin concentration is lower during IP insulin therapy compared to SC insulin. Insulin has probably a direct effect on both peritoneal leptin clearance and adipose tissue leptin production. The significance of leptin in regulating appetite and anorexia in uremia remains unclear.

Adult↗

Results of obesity treatment.

Obesity is a chronic disease so that results of obesity treatment should only be evaluated on a long-term basis. The present paper aims at analyzing the long-term (1 year or more) results of three anti-obesity approaches, i.e. lifestyle modifications, pharmacological treatments and surgical procedures. Dietary interventions include diets with moderate calorie restriction and very-low energy diets (VLED). Even if an initial greater weight loss is observed with VLED, no study has conclusively shown that the long-term approaches including VLED are better than non-VLED programmes. Physical activity is not the most efficient method of initial weight loss, but it appears to be more crucial for maintaining weight loss once it has occurred. In general, long-term results of lifestyle modifications are disappointing because of poor compliance. Several 1-2 year large-scale randomized placebo-controlled clinical trials with orlistat, an intestinal lipase inhibitor, and sibutramine, a central appetite regulator, have demonstrated that both drugs significantly, although modestly on average, increase weight reduction, almost double the number of responders (weight loss >=5 or 10% of initial body weight) and improve weight maintenance up to 2 years. Surgical procedures provide a much greater weight reduction than medical interventions in patients with morbid obesity, particularly after a follow-up of several years. Weight loss is greater with gastric bypass, inducing some malbsorption, than with gastroplasty, a pure gastric restriction technique. Associated risk factors such as markers of insulin resistance syndrome and type 2 diabetes are remarkably reduced, but no prospective study of morbidity or mortality is available yet. In all cases, the management of obesity requires a multidisciplinary approach to improve the success rate.

Humans↗

Effects of agouti-related protein, orexin and melanin-concentrating hormone on oxygen consumption in mice.

Neuropeptides in the hypothalamus play a pivotal role in the regulation of energy balance. Agouti-related protein (AGRP), orexin and melanin-concentrating hormone (MCH) have been identified in the hypothalamus as orexigenic peptides. This study was undertaken to investigate the effects of AGRP, orexin and MCH on oxygen consumption. Oxygen consumption was determined by an O2/CO2 metabolism measuring system at 22 degrees C. Mice were kept unrestrained in the chamber without food or water during the light cycle, and the oxygen consumption was measured for 2 h after intra-cerebroventricular (ICV) administration. ICV administered AGRP (1 nmol/mouse) significantly decreased oxygen consumption compared to ACSF-treated controls. Orexin (1 nmol/mouse) significantly increased oxygen consumption, while MCH (1 nmol/mouse) had no significant effect compared to ACSF-treated controls. These results suggest that AGRP, orexin and MCH might have different effects on energy expenditure, thereby regulating appetite and body weight.

Agouti-Related Protein↗

[Obesity: therapeutic aspects].

Obesity is now recognized as a chronic disease. Its treatment implies a prolonged negative energy balance, by reducing caloric intake and/or increasing energy expenditure. In practice, three therapeutic approaches can be considered: 1) life-style modifications, combining well-balanced hypocaloric diet and regular physical exercise, the key-issue in obesity management; 2) in case of failure and as adjunct treatment, anti-obesity drugs, especially orlistat, an intestinal lipase inhibitor, and sibutramine, a central appetite regulator; and 3) in patients with extreme refractory obesity, surgical procedures consisting of gastric restriction (gastroplasty) or intestinal bypass. Anti-obesity treatments must be evaluated in the long run, in terms of efficacy/safety ratio, upon criteria of weight loss, reduction in associated risk factors, improvement of quality of life and, if possible, reduction of morbidity and mortality.

Humans↗

[Progress in the study of obesity].

Obesity has been rising as a common social phenomenon. Recent research has convinced us that rather than a cosmetic problem, obesity should be considered as a real disease which is a complex disorder of appetite regulation and energy metabolism. Actually, obesity is caused by many factors such as heredity, environment and food contents, among which hereditary gene seems to work as a key element. Induced and followed by complicated factors, obesity is particularly associated with diabetes mellitus II, coronary heart disease, certain forms of cancer and so on. At present, the access to treat obesity is still in its early stage and the function of leptin identified in 1994 is also the focus of debate. This review provides a comprehensive insight into the epidemics, etiology, healthy problems, treatment strategies of obesity, and leptin as well, attempting to develop an outline of obesity research.

Humans↗

[Leptin and thyroid hormones].

Leptin, a satiety hormone is a protein produced by the adipose tissue that regulates appetite and energetic balance of the body. Results of investigations of serum leptin in patients with hyperthyroidism or hypothyroidism are controversial. Influence of thyroid hormones on leptin secretion is complex and partially unrecognized.

Adipose Tissue↗

Genetic and physiological factors in obesity.

Body weight is determined by the interaction of the genetic makeup of an individual and the environment in which that person is living. The control systems that regulate body weight are numerous and include signals from fat that travel to the hypothalamus where cognitive and internal signals are integrated. The integration of these signals involves a complex array of neuropeptides, neurotransmitters and structural circuits. These circuits regulate appetite, intake and energy expenditure. Recent studies demonstrate that the theory of a thrifty genotype is probably correct. Some people are more susceptible to our obesogenic environment than others. Some people are able to overwhelm their genetics by voluntarily increasing energy expenditure and decreasing food intake; a feat that is rarely accomplished and requires a Herculean effort. As we better understand the environmental, genetic, physiological, and behavioral aspects of obesity, we will undoubtedly develop better strategies and therapies for obesity.

Body Mass Index↗

Ghrelin, peptide YY and their receptors: gene expression in brain from subjects with and without Prader-Willi syndrome.

Ghrelin and peptide YY (PYY) are peptides generally produced by the gastrointestinal organs which are involved in appetite regulation via highly specialized centers in the brain. Abnormal plasma ghrelin and PYY levels compared with controls have been reported for subjects with Prader-Willi syndrome (PWS) which is characterized by infantile hypotonia, poor suck reflex and failure to thrive followed by hyperphagia and marked obesity in early childhood. We studied gene expression of ghrelin, peptide YY, and their receptors (i.e., GHS-R1a, GHS-R1b, and NPY2R) in six different brain regions (frontal cortex, temporal cortex, visual cortex, pons, medulla, and hypothalamus) obtained from three subjects with PWS, two individuals with Angelman syndrome, and six controls to determine if expression of these genes is detectable in different regions of the brain in subjects with and without PWS. In general, expression of these genes using RT-PCR was detected in all subjects and no obvious differences were seen in their pattern of expression between subjects with or without PWS. Additional studies including quantitative gene expression measurements will be required to further evaluate the role of these genes in the eating disorder seen in PWS.

Adult↗

[Ghrelin--a hormone with multiple functions].

The growth hormone secretagogue ghrelin is in the centre of interest since its discovery in 1999. It stimulates growth hormone, corticotropic hormone and prolactin secretion, but also plays an important role in the regulation of appetite, carbohydrate- and lipid metabolism and possibly on gastric acid secretion, gastric motility, heart function and as well as immune functions and cell proliferation. Ghrelin was originally identified from the stomach but it is also present in all tissue among others in: hypothalamus, pituitary, pancreas, lung, immune cells, placenta, ovary, testis, kidney and in different tumours including pituitary adenoma, neuroendocrine tumours, thyroid carcinomas, endocrine tumours of the pancreas and lung. The gene structure and its receptor are similar to motilin, they are both synthesized in the upper gastrointestinal tract and both have prokinetic activity on gut motility. The ghrelin receptor (growth hormone secretagogue receptor) is a member of G protein-coupled seven transmembrane domain receptor. The receptor is localised in the central nervous system, kidney, thyroid, pancreas, myocardium and spleen. Starvation and low body mass index decrease, while food intake, hyperglycaemia, elevated insulin levels and high body mass index increase the endogenous ghrelin levels. Although we know much about the ghrelin, number of questions remain unanswered, such as the effects of the locally-produced ghrelin or its role in the cell metabolism.

Animals↗

Pathogenesis and pharmacologic treatment of obesity: the role of energy regulatory mechanism.

Obesity has become a worldwide public health problem affecting millions of people. This is a chronic, stigmatized, and costly disease, rarely curable and is increasing in prevalence to a point today where we define obesity as an epidemic disease that not only in developed but also on developing countries. The pathogenesis of obesity is largely unknown, especially about energy regulatory mechanism that involved wide area of neuroendocrinology that is very interesting but very complex and makes internists "refuse" to learn. Obesity occurs through a longstanding imbalance between energy intake and energy expenditure, influenced by a complex biologic system that regulates appetite and adiposity. Obesity influences the pathogenesis of hypertension, type 2 diabetes, dyslipidemia, kidney, heart, and cerebrovascular disease. It is very wise for every internist to learn the pathogenesis and treatment of this worldwide diseases. Until now, the available treatments, including drugs, are palliative and are effective only while the treatment is being actively used; and besides so many side effects reported.

Appetite Depressants↗

[Cord blood leptin concentration and somatic parameters of smoking mother's newborns].

Leptin is a peptide synthesised in white fat tissue adipocytes. It plays a key role in appetite regulation and body mass development. The leptin's concentration is correlated with body fat magazines. This hormone has also anorectic and sympatheticomimetic function. Leptin's concentration measured early after birth is strictly connected with birth-weight. Smoking during pregnancy leads to decrease of plasma leptin concentration in newborn. The aim of the study was estimation of the leptin level in umbilical cord blood of children born from smoking and no-smoking women. Some other somatic parameters were also analysed. A cohort of 210 women and their children born in the Institute of Obstetrics and Gynaecology Medical University of Gdansk was examined. The estimation of frequency of smoking during pregnancy was analysed by questionnaire done in this group. Samples of the umbilical cord blood were collected after birth and leptin concentration was analysed by standard RIA method. Significantly lower leptin concentration in smoking mothers' newborns was stated. Children born from smoking mothers had significantly lower birth weight and length. The frequency of smoking during pregnancy in analysed region is lower in compare to previous years.

Adipocytes↗

Postprandial leptin response to Thai meals with different macronutrient mixtures.

The objective of this study was to investigate the postprandial response of leptin, an appetite-regulating hormone, to different macronutrient mixtures in Thai meals. A within-subject repeat measurement was performed. Two groups of healthy Thais (10 men and 10 women in each group) received a single meal of equal calories composed either a high carbohydrate, low fat, low protein diet (HC-LFLP, carbohydrate:fat:protein = 70%:15%:15%) or a low carbohydrate, high fat, high protein diet (LC-HFHP, carbohydrate:fat:protein = 20%:50%:30%). Fasting and 30-minute interval postprandial blood levels of leptin, insulin and glucose were measured for a 2-hour period. In comparison to the LC-HFHP meal, the HC-LFLP meal produced a greater increase in glucose and insulin levels, but halted leptin from decreasing. Postprandial leptin levels were suppressed by a LC-HFHP meal but not by a HC-LFLP meal. The reduced leptin in conjunction with lower glucose and insulin levels may encourage overeating in habitual LC-HFHP diet consumers.

Adult↗

Hypothalamic regulatory peptide disturbances in the spontaneously obese JCR: LA-corpulent rat.

Central and lateral hypothalamic concentrations of 9 regulatory peptides implicated in the control of feeding behaviour were measured in corpulent (cp/cp) JCR:LA-cp rats which develop spontaneous obesity, hyperinsulinaemia and hyperlipidaemia, and in lean (+/?) controls. In female cp/cp rats, central hypothalamic levels of neuropeptide Y (NPY), neurotensin, somatostatin and substance P were significantly lower (p less than 0.02) than in lean female controls. Following food restriction with a 16% reduction in body weight, these differences were apparently reversed and there were also significant rises in the lateral hypothalamic concentrations of neurotensin and of galanin. The other 4 peptides examined (bombesin, calcitonin gene-related peptide, neuromedin B and vasoactive intestinal peptide) did not differ significantly between cp/cp and lean females, either fed freely or food-restricted. Male cp/cp rats showed no significant differences from lean males in central or lateral hypothalamic concentrations of any of the 9 peptides. NPY and galanin are powerful and specific central appetite stimulants, whereas neurotensin, substance P and somatostatin inhibit feeding when injected centrally. Disturbances in these putative appetite-regulating peptides may be involved in the hyperphagia and other hypothalamic abnormalities in this spontaneous obesity syndrome. The apparent absence of differences between the male corpulent and lean groups may relate to sexual dimorphism of the syndrome, which is more marked in the females.

Animals↗

Serum salivary isoamylase levels in patients with anorexia nervosa, bulimia or bulimia nervosa.

Salivary isoamylase levels were studied in a sample of 35 women with bulimia, anorexia nervosa, or bulimia nervosa. Salivary isoamylase elevation was related to the presence of sham eating, evidenced by elevated isoamylase values in patients with bulimia nervosa or bulimia, and depressed isoamylase values in patients with anorexia nervosa. Salivary isoamylase levels may provide insight and have bearing on the functional interrelationship between appetite regulation and ingestive behavior in patients with eating disorders, as abnormalities may occur during both the cephalic as well as the oral phase of eating.

Adolescent↗

[Correlation of glycerin-level and body weight (author's transl)].

In 202 non selected males and females the concentration of free glycerin in the fasting serum was evaluated. There was a significant parabolic correlation of the glycerin-levels in the serum with the deviation of the actual body weight from the ideal weight. There is a theory that glycerin regulates the appetite through a negative feed-back mechanism. Our findings do not contradict this hypothesis, as it cannot be excluded that feedback mechanism is disturbed in long lasting obesity. The serum level of free glycerin is not correlated with the concentration of triglycerides or total cholesterol.

Adult↗

Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity.

Twenty-three morbidly obese and 17 control subjects were studied with a breakfast meal. Neither fasting nor postprandial plasma pancreatic polypeptide (PP) levels differed significantly between the two groups, whereas postprandial serum insulin and blood glucose were significantly higher in the obese subjects. Our results do not support the suggestion that PP participates in the appetite regulation or the development of obesity.

Adult↗

Obesity and physical activity.

Obesity has a close connection with energy balance. Available methods of measurement are, however, too coarse to measure minor daily oscillations that over the months or years can indicate a rise of several kilograms. Basal metabolism is an important part of total energy consumption. This varies with age, sex and body composition. Several investigations appear to show that physical activity can raise basal metabolism. With the help of direct and indirect calorimetry it has been possible to calculate energy consumption above the basal figure. However, in calculating the energy gain through exercise it is necessary to subtract the energy consumption that would otherwise have taken place. Theories have been put forward that the different types of overweight (hyperplastic and hypertrophic) show different gains from physical training as regards weight reduction. However, classification of overweight persons in groups is somewhat uncertain. Physical activity has been found to restore to normal the metabolic changes which are often associated with obesity. There are also cases in which no loss of weight occurs. Physical training has a favourable effect in regulating appetite. Dropout from training programmes is considerable in the overweight. Associated locomotor symptoms may also complicate training. Even though there is little evidence in the literature to show that the majority of overweight persons lose significant amounts of weight without accompanying dietic restrictions, physical training is undoubtedly of great value in these groups.

Appetite↗